Precancerous Gastric Lesions with Helicobacter pylori vacA+babA2+oipA+ Genotype Increase the Risk of Gastric Cancer

الملخص EN

Objective.

The clinical outcomes of gastric diseases such as chronic gastritis, peptic ulcer, and gastric cancer have been attributed to the interplay of virulence factors of Helicobacter pylori (H.

pylori), host genetic susceptibility, and host immune responses.

This study investigated the presence of cagA, vacA, iceA2, babA2, and oipA genes and their association with clinical outcomes.

Methods.

Chronic gastritis, atrophic gastritis, and intestinal metaplasia specimens were obtained from patients who underwent endoscopy and surgical resection between January 2017 and December 2018; specimens from gastric cancer patients treated between January 2014 and December 2018 were also added.

H.

pylori infection and virulence genes (cagA, vacA, iceA2, babA2, and oipA) were determined using real-time PCR.

The association between H.

pylori genotypes and clinical outcomes were evaluated using multivariate regression model analysis.

The overall survival of gastric cancer patients was compared between genotype combinations.

Results.

H.

pylori was positive in 166 patients with chronic gastritis, precancerous gastric lesions, and gastric cancer.

The genes vacA, babA2, and oipA were most prevalent in chronic gastritis (73%), precancerous gastric lesions (62%), and gastric cancer (91%), respectively.

The vacA, babA2, and oipA genes were associated with increased risk of gastric cancer (OR = 1.23; 95% CI = 1.13–3.32; P=0.033, OR = 2.64; 95% CI = 1.44–4.82, P=0.024, and OR = 2.79; 95% CI = 1.58–5.41; P=0.031, respectively).

Interestingly, H.

pylori vacA+/babA2+/oipA+ genotype infection was associated with increased risk of gastric cancer (OR = 3.85, 95% CI = 1.67–5.77, P=0.014).

Conclusion.

In this present study, we reported on the virulence genes of H.

pylori infection to reveal their association with increased risk of chronic gastritis, precancerous gastric lesions, and gastric cancer.

Precancerous gastric lesions with H.

pylori vacA+/babA2+/oipA+ genotype increased the risk of gastric cancer.